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Background: A differential contribution of the right and left amygdalae to affective information processing has been
proposed. However, the direction of this lateralization has not been confirmed. In this study, we used a pre- and
post-treatment (escitalopram) design to analyze the relative differences between neural activity in the right and
left amygdalae during exposure to emotional stimuli in currently depressed patients. To the best of our knowledge, this
study is to compare neural activity between the left and right amygdalae in people with depression. Our findings could
lead to the development of parameters or biomarkers for depressive symptoms and treatment response.
Methods: We used a pre–post-test design without a control group. Twenty currently depressed participants
underwent an emotion processing task during fMRI. These participants were then treated with an antidepressant
for 6 weeks. We used amygdala region-of-interest analysis to evaluate the hemodynamic response during exposure to
colored emotional pictures.
Results: In total, thirteen of the 20 participants were placed into a separate group based on degree of response to
antidepressants. The partial response group had an averaged HDRS score of 10.75 ± 2.25 and an averaged DBOLDLR
signal of 189.18 ± 140.23 (m1 = 8), and the remitted group had an averaged HDRS score of 4.80 ± 1.64 and an averaged
DBOLDLR signal of 421.26 ± 109.19 (m2 = 5). Each individual had lateralized amygdala activity, and the direction of
asymmetry persisted following treatment. Amygdala responses to four types of emotional stimuli did not significantly
change (p > 0.05) with treatment in either the right or the left amygdala. However, the difference in neural activity
between the right and left amygdalae was greater after treatment, and the variation in neural activity was larger in the
left amygdala.
Conclusions: We found that the response between the right and left amygdala did not differ in terms of time series,
although activity increased after pharmaceutical treatment for each emotion tested. In the future, changes in BOLD
signals as revealed by fMRI might be useful in evaluating the clinical manifestation of major depression.
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Both animal studies and human studies with non-invasive
techniques have indicated that the amygdala plays a crucial
role in emotional processing [1-3]. Memories about a
stimulus that are stored in the hippocampus can pre-
dict activation in the amygdala in response to the
stimulus, indicating that the amygdala receives sensory* Correspondence: cjhou@mail.stust.edu.tw
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unless otherwise stated.input [4]. Impairments in emotional empathy have been
mostly studied in people with neurological diseases
with relatively diffuse injuries, such as traumatic brain
injury, autism, and dementia [5]. Lesions of the amygdala
caused by surgery or degenerative disease can impair emo-
tional facial expression recognition, particularly for fearful
expressions [6]. Neuroimaging studies in healthy partici-
pants have described a large increase in amygdala activity
while individuals view photos of faces with fearful expres-
sions [7,8] and other emotionally valenced stimuli [9-12].
As individual studies have used varying paradigms and aretd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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whether the left or right amygdala is more consistently
involved in emotional processing. Across studies, the
left amygdala appears to be activated more often than
the right amygdala, suggesting different roles for the
left and right amygdalae in emotional processing [13].
Some studies have highlighted sex as a potential modu-
latory factor in emotional processing and its underlying
neural mechanisms, and more broadly, the need to con-
sider individual differences in understanding the neurobiol-
ogy of emotion [14]. One study, which used quantitative
meta-analysis, found no evidence to support amygdala
lateralization as a function of sex or valence. Instead, their
findings provided strong support for a functional dissoci-
ation between the left and right amygdala in terms of tem-
poral dynamics [15].
Several fMRI studies have found increased amygdala ac-
tivation in relation to self-reported anxiety and depression
[16-18]. One common probe of human amygdala function
is the identification of emotional facial expressions. Re-
sults from several functional neuroimaging studies have
suggested that in healthy adults, the amygdala responds
more strongly to fearful faces than to other expressions,
such as neutral or happy faces [8,11,12,19,20]. This pattern
of activity is generally lateralized, with a greater response
in the left amygdala for standard face presentations. How-
ever, when facial expressions are masked so that the initial
emotion is not consciously perceived, the right amygdala
shows greater activation [8,12,20]. Additionally, adults
with amygdala lesions exhibit deficits in their ability to
recognize certain facial expressions, especially fearful ex-
pressions [6,21-24]. In recent years, many researchers have
investigated the role of the amygdala in emotional pro-
cessing, learning, and memory. While most reports have
emphasized the role of the amygdala in emotional pro-
cessing, few have examined the differential contributions
of the right and left amygdalae to affective information
processing [25]. Many studies have observed lateralized
amygdala activity, which is indicative of a hemisphere-
specific processing difference between the left and right
amygdalae. However, the direction of the reported
lateralization is inconsistent [26]. In one study, the re-
searchers hypothesized that in females with Turner
syndrome, the right and left amygdalae play distinct but
complementary roles that influence somatic and cognitive
responses to emotional stimuli [27]. Right amygdala acti-
vation is associated with autonomic arousal, which indir-
ectly influences cognitive processing centers in the left
hemisphere, whereas left amygdala activation is linked to
cognitive processing and recognition of emotional stimuli
[27]. Some researchers have proposed that the left amyg-
dala is more closely related to affective information encod-
ing with a higher affinity for detailed feature extraction,
while the right amygdala has a higher affinity for retrievalof pictorial or image-related affective information. Thus,
the right amygdala may be involved in a faster but more
superficial analysis of emotional stimuli compared with
the left amygdala. These findings indicate that the left
amygdala is more closely involved in language processing,
while the right amygdala is more strongly engaged during
fast, superficial, or gross analyses of affect-related informa-
tion [26].
Several investigations have produced evidence that
SSRIs act via the attenuation of activation in brain regions
responsible for emotion processing. Such data provides
support for the potential of fMRI with pharmacological
probes as a way to identify the specific therapeutic effects
of pharmaceutical agents in patients with anxiety and
mood disorders [26]. For instance, one study showed that
both escitalopram and citalopram decreased BOLD-signal
activation in the amygdala and parahippocampal cortex in
response to emotionally significant stimuli [26]. Another
study indicated that antidepressant treatment reduces left
limbic, subcortical, and neocortical capacity for activation
in depressed participants and increases the dynamic range
of the left prefrontal cortex. Changes in anterior cingulate
function associated with symptomatic improvements
indicate that fMRI may be a useful surrogate marker of
antidepressant treatment response [28]. Fu et al. dem-
onstrated that patients with depression had decreased
neural responses to happy facial expressions in limbic,
subcortical, and extrastriate cortical regions compared
with healthy volunteers [29]. However, Arnone et al.
showed that aberrant amygdala activation in response
to sad facial emotions was specific to the depressed state,
making it a potential biomarker for negative affective bias
during a depressive episode [30]. Victor et al. suggested
that antidepressant drugs exert their primary therapeutic
mechanism by normalizing negative bias in information
processing. This hypothesis was based partly on the find-
ing that short-term administration of citalopram in
healthy individuals enhanced the amygdala response to
happy faces, while in depressed individuals a single-dose
of reboxetine enhanced the behavioral responses to posi-
tively valenced stimuli [31].
In the present study, which had a longitudinal design,
we used an emotion processing task during fMRI to exam-
ine whether abnormal amygdala responses to emotional
stimuli were related to specific emotions or changes in the
response of depressed participants to their antidepressant
treatment. In addition, we investigated whether neural
activity would differ over time between the right and left
amygdalae in response to emotional stimuli. The aim of
this study was to analyze the relative differences in neural
activity between the right and left amygdalae in cur-
rently depressed patients during exposure to emotional
stimuli in pre- and post-test (escitalopram) conditions.
Most previous studies have investigated changes in neural
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explicitly presented stimuli, or the differential amygdala
response to facial stimuli. To the best of our knowledge,
this is the first study to find a relative difference in neural
activities between the left and right amygdala in individ-
uals with depression. These findings could lead to useful




The participant group comprised 20 individuals aged
28–55 years with a mean and standard deviation (SD)
of 45.71 ± 8.04 who were not currently receiving medi-
cation for depression (N = 20). Previously, most of the
participants had received antidepressants (escitalopram)
for 6 weeks and several had been treated with hypnotics
(Estazolam). The participants reported no co-morbid con-
ditions. The participants were recruited from the out-
patient clinic at the Department of Psychiatry, Chiayi and
Wanqiao Branch, Taichung Veterans General Hospital,Figure 1 Patient characteristics. A total of 20 (N) patients were enrolled.
evaluation at week 6. Among them, a total of 13 (n2) participants (65%) ha
participants (25%) were in remission at week 6. The patient characteristics aChiayi, Taiwan. Participants underwent screening that
included their medical and psychiatric history, laboratory
testing, drug screening, a physical examination, and a neu-
romorphological MRI. Psychiatric diagnosis of depression
was established using the Structured Clinical Interview
from the DSM-IV and a semi-structured interview con-
ducted by a research psychiatrist. Severity of illness was
established using the 17-item Hamilton Depression Rating
Scale (HDRS). One clinician assessed all participants.
Patients with HDRS scores ≥18 were eligible for this study.
Participants were excluded if they had (1) a moderate to
severe suicidal risk; (2) major medical or neurological dis-
orders, such as stroke, tumors, or Alzheimer’s disease; (3)
substance abuse or dependence (including alcohol) within
the past 6 months; (4) pregnancy, risk of pregnancy, or
lactation; (5) general MRI incompatibility; (6) any his-
tory of a psychotic disorder, including bipolar I/II. After
receiving a complete explanation of the study procedures,
all participants provided written informed consent as
approved by the institutional review board. This study was
approved by the ethics committee of Taichung VeteransAmong them, a total of 20 participants (100%) completed an
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Figure 2 Design of the emotion processing task. Emotion i (i = 1,…,4) represents a certain emotional picture set comprising 10 pictures of
happiness (H), sadness (S), fear (F), or disgust (D). Each picture was randomly displayed for 3 seconds, giving each emotional picture set a total
presentation length of 30 seconds. The time intervals for each set of instructions and each rest were 15 and 30 seconds, respectively. The total
task length was 5 minutes and 15 seconds.
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Clinical Practice procedures and the current revision of
the Declaration of Helsinki [32].Antidepressant drug treatment
After the initial assessment, we conducted a baseline
MRI scan and prescribed antidepressants (escitalopram)
to each participant (visit 1). They returned for a second
scan (visit 2) after 6 weeks. The participants were main-
tained on stable dosages (20 mg) throughout the 6-week
period (Figure 1).Figure 3 Reconstruction of 3D models of the brain and skull.Emotional processing task
Participants underwent fMRI while completing an emo-
tion processing task (Figure 2). The task consisted of the
blocked presentation of colored pictures from the Inter-
national Affective Pictures System (IAPS). The IAPS im-
ages, including four emotional picture sets featuring
images of happiness (H), sadness (S), fear (F) and disgust
(D), were generated by a Pentium dual core PC and pre-
sented on a back projection screen that was visible to
the participant via a mirror attached to the head coil.
Each emotional picture set comprised 10 pictures and
each picture was randomly displayed for 3 seconds, giv-
ing each emotional picture set a total length of 30 sec-
onds. We presented stimuli in 11 time intervals, which
included the instructions at the start and end of the task,
four emotional picture sets, and five time intervals
between the instructions and each emotional picture set.
The total task length was 5 minutes and 15 seconds.
The display of the video and the fMRI scanning was trig-
gered at the same time for synchronous signal recording.
fMRI data acquisition
Images were obtained using a 1.5-T Signa HDx system (GE
Healthcare, United Kingdom) with a standard RF receiver
head coil. A total of 105 fMRI images were acquired in
each task period. To provide an anatomical framework for
analysis of the fMRI images, we obtained high-resolution
anatomical images using a gradient-echo EPI imaging se-
quence (TR = 3000 ms; TE = 50 ms; matrix: 64 × 64), which
created transversal whole-brain acquisitions (26 slices,
4 mm slice thickness, 0 mm interslice gap). In addition, we
conducted a coronal three-dimensional (3D) gradient-echo
Figure 4 Temporal evolution of the BOLD signal in the left and right amygdalae. The time series was plotted against the magnitude of the
BOLD signal. BOLD = blood oxygen level dependent.
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TE = 5.2 ms, 132 slices).Image calibration and amygdala tracing
Functional imaging analyses and amygdala tracings were
performed using the general linear model with Statistical
Parametric Mapping (SPM, Wellcome Trust Centre for
Neuroimaging, London, England; http://www.fil.ion.ucl.ac.
uk/spm). During fMRI scanning, unplanned head move-
ments can result in inaccurate localization of activity.
SPM enables every slice in an fMRI image sequence to be
realigned for motion correction of individual head
movements, and the resliced image sequence to be gen-
erated. Whole-brain fMRI volumes were realigned to
the first volume, coregistered to each participant’s ana-
tomical data, and normalized to fit a standard brain
template (structural T1 images).Figure 5 Example of the DBOLDLR signals for each fMRI image. DBOLDLR3D registration
We used the coregistered MRI and fMRI image sequences
to construct, spatially register, and fuse the 3D models of
fMRI and MRI data using the Avizo system (VSG Inc.,
USA). Avizo is a type of commercial software that enables
users to perform interactive visualization and computation
on 3D data sets. We developed a procedure for amygdalae
tracing and evaluating using the Tool Command Language
(Tcl) in Avizo. A senior physician identified the amygdalae
from the virtual MRI slices of the reconstructed 3D model
(Figure 3). The spatially-related locations of the amyg-
dalae in the time sequence of the virtual fMRI 3D model
were automatically placed to trace the neural responses
of amygdalae activation.
Temporal evolution of the neural responses to the task
The hemodynamic responses in the amygdalae during vis-
ual stimulation with emotional images varied in intensity.: the difference in the BOLD signal between the right and left amygdalae.
Figure 6 Example of pre-treatment amygdala responses to four types of emotional stimuli in the left and right amygdalae.
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(BOLD) signal was measured in each fMRI phase and
the time course of the BOLD signal change plotted ac-
cordingly (Figure 4).
Indexes for the evaluation of amygdalae activation
We used the BOLD signal in each amygdala and the
difference in the BOLD signal between the right and left
amygdalae (DBOLDLR) to investigate amygdalae activa-
tion. The DBOLDLR signal was computed by the follow-
ing equation:
DBOLDLR ¼ IL−IRj j;
where IL represents the BOLD signal in the left amygdala
at a specific time point and IR represents the BOLD sig-
nal in the right amygdala at a specific time point. TheFigure 7 Example of post-treatment amygdala responses to four typefull time course of the DBOLDLR signal is presented as a
curve in Figure 5.Statistics
Our study had a two-factor design. Factor A had two
levels: pre- and post-treatments, and Factor B had four
levels: happiness, sadness, fear and disgust. We carried
out a two-way ANOVA with repeated measures to 1)
compare the BOLD signals and the DBOLDLR signals in
the pretreatment group with those in the post-treatment
group, 2) test the BOLD signals and the DBOLDLR sig-
nals among the four types of emotional stimuli, and 3)
test the interaction between Factor A and Factor B using
SPSS 17.0 statistical software. We used a paired t test to
compare the HDRS scores in the pre-treatment group
with those in the post-treatment group. We used a sim-
ple linear-regression method to analyze the relationships of emotional stimuli in left and right amygdalae.
Figure 8 Hemodynamic response to each of the four emotional stimuli after antidepressant treatment did not differ significantly from
that before treatment in the right amygdala. Error bars indicate standard deviations. BOLD = blood oxygen level dependent.
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and post-treatment groups.
Results
Figures 6 and 7 show the pre-treatment and post-
treatment amygdala (right and left) responses to each of
the four emotional stimuli, respectively. Among the 20
participants, six had greater pre-treatment responses in
the left amygdala than in the right, and the remaining par-
ticipants had greater pre-treatment responses in the right
amygdala. Each individual showed lateralized amygdala
activity, and the direction of asymmetry remained consist-
ent throughout the treatment period. Seventeen partici-
pants exhibited an increase in the post-treatment BOLD
signal, while the BOLD signal was attenuated in the
other three. The results of a two-way ANOVA with re-
peated measures revealed that the BOLD signals in the
amygdalae of the 20 participants were not significantlyFigure 9 Hemodynamic response to each of the four emotional stimu
that before treatment in the left amygdala. Error bars indicate standarddifferent between the pre- and post-treatment periods
among the four types of emotional stimuli (Figures 8
and 9).
The means and standard deviations of the DBOLDLR
signals for all participants in the pre- and post- treatment
groups are shown in Table 1. Compared with that in the
pre-treatment group, the DBOLDLR signals in the post-
treatment group were greater in response to the four types
of emotional stimuli (Figure 10). A two-way ANOVA
with repeated measures revealed a significant effect of
factor A on the DBOLDLR signals (pre-treatment vs. post-
treatment) (F = 9.350, p < 0.05), a non-significant effect of
factor B on the DBOLDLR signals (happiness, sadness,
fear and disgust) (F = 0.608, p > 0.05), and no statistically
significant interaction between factor A and factor B
(F = 0.120, p > 0.05), as shown in Table 2.
The mean and standard deviation of HDRS score was
19.55 ± 2.06 in the pre-treatment group, and 11.80 ± 5.60li after antidepressant treatment did not differ significantly from
deviations. BOLD = blood oxygen level dependent.
Table 1 The mean and standard deviation of DBOLDLR signals response to four types of emotional stimuli in the
pre- and post-treatment groups (N = 20)
Happiness Sadness Fear Disgust
Mean ± SD Mean ± SD Mean ± SD Mean ± SD
pre-treatment 124.19 ± 134.50 122.76 ± 132.60 125.42 ± 134.53 126.05 ± 134.07
post-treatment 245.34 ± 175.25 245.22 ± 179.33s 245.86 ± 181.94 246.56 ± 182.73
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nificant differences in HDRS score between the pre- and
post-treatment groups (t = 7, p < 0.05) (Figure 1). The
HDRS scores of 13 participants after antidepressant treat-
ment were below 14 with an average of 8.46 and a SD of
3.60. The mean and SD of the DBOLDLR signals was
278.44 ± 171.09 (n2 = 13). The other seven patients had
post-treatment HDRS scores that were greater than or
equal to 14 (n1 = 7), an average HDRS score of 18.00 ±
2.08, and an averaged DBOLDLR signal of 183.12 ± 186.33
(Figure 1). Thirteen of the 20 participants were placed into
a separate group based on degree of response to antide-
pressants. The partial response group had an averaged
HDRS score of 10.75 ± 2.25 and an averaged DBOLDLR
signal of 189.18 ± 140.23 (m1 = 8), and the remitted group
had an averaged HDRS score of 4.80 ± 1.64 and an aver-
aged DBOLDLR signal of 421.26 ± 109.19 (m2 = 5). These
data indicate that the greater the clinical response to anti-
depressant treatment, the greater the increase in neural
activity in the amygdala.
Figure 11 shows a scatter plot of the DBOLDLR signal
versus the HDRS scores for the pre- and post-treatment
groups. The red cross (x) marks the DBOLDLR signals
versus the HDRS scores of the 20 participants in the pre-
treatment group. The blue circle (o) marks the DBOLDLR
signals versus the HDRS scores of the 20 participants in
the post-treatment group. We conducted a linear regres-
sion analysis with the following linear regression equation:
y = −13.139x + 390.392 (R2 = 0.203, F = 9.662, p = 0.004).Figure 10 DBOLDLR signal responses to four emotional stimuli in theThe purpose was to assess the relationship between HDRS
scores and the DBOLDLR signal. The centroids of the pre-
and post-treatment groups revealed that improved HDRS
scores were correlated with increased DBOLDLR signals,
which implied an increase in the hemodynamic response
difference between the right and left amygdala.
Discussion
A computational neural network model of emotional
information processing suggests that this process involves
sustained amygdala activity elicited by the negative fea-
tures of stimuli [33]. One study found that depression
patients whose sustained reactivity to emotional stimuli
was high in the amygdala exhibited the strongest improve-
ments with cognitive behavioral therapy (CBT) [34]. Some
studies have reported that depression patients exhibit
hyperarousal in the left amygdala, even when processing
stimuli outside conscious awareness. This increased amyg-
dala activation tends to normalize with antidepressant
treatment [35]. Gaffrey reported a strong positive relation-
ship between major depressive disorder (MDD) severity
and activity level in the right (r = .709, p = .007) rather
than the left (r = .421, p = .099) amygdala during the pres-
entation of sad faces [36]. In our study, we found that
six depressive patients had greater activation in the
right amygdala and 14 depressive patients had greater
activation in the left amygdala prior to antidepressant
treatment. In cases where patients had higher activation in
one amygdala before the treatment, this persisted after thepre- and post-treatment groups.
Table 2 Display of two-way ANOVA with repeated measures results (N = 20)
Source of variation Sum of squares df MS F p-value PES
A factors 586990.48 1 586990.48 9.350 0.006** 0.330
B factors 122.663 3 40.888 0.608 0.613 0.031
A × B interaction 26.275 3 8.758 0.120 0.948 0.006
df: degrees of freedom; MS: mean squares; PES = Partial Eta Squared; **: p < 0.05.
The DBOLDLR signals of factor A revealed a significant difference between pre- and post-treatment groups. A factors represent pre- and post-treatment, and B
factors represent four emotional stimuli. The p-value < 0.05 indicates a significant difference statistically.
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amygdala elicited by four emotional stimuli were clearly
lower after the treatment (Figure 9). This decrease in
BOLD signals implies an improvement in depressive
symptoms resulting from the antidepressant treatment,
according to some studies [35]. The large variance in
BOLD signals among the 20 participants resulted in no
statistically significant differences between the pre- and
post-treatment groups. However, a bilateral difference in
DBOLDLR signals emerged when symptoms improved in
response to medication. Our pre-treatment findings were
inconsistent with those of a previous study by Gaffrey and
colleagues [36]. This inconsistency may be explained by
the following: 1) sample size and age differences: 20 adults
participated in our study, whereas 11 preschool children
were enrolled in Gaffrey’s study; 2) study aim: our study
examined patterns of amygdala responses to emotional






















Figure 11 Scatter plot of DBOLDLR signals versus HDRS scores for the
DBOLDLR signals versus the HDRS scores obtained by the 20 participants in
signals versus the HDRS scores obtained by the 20 participants in the post
the centroids of the pre- and post-treatment groups. The linear regression
p = 0.004). DBOLDLR: the difference in the BOLD signal between the right aregression model: we analyzed the relationship between
HDRS scores and the difference in response between the
right and left amygdalae, whereas Gaffrey’s study analyzed
the relationship between MDD severity and activity level
in the right vs. left amygdala.
Peluso et al. demonstrated greater amygdala activation,
in both the right and left amygdalae, in unipolar depressed
individuals compared with non-depressed healthy individ-
uals. In their study, increased depressive symptoms were
associated with stronger amygdala activation [31]. Our
findings may differ from those of Peluso et al. for the
following reasons: 1) differences in sample size between
our study and Peluso’s study; 2) more severe or persistent
forms of mental illness may be related to pathological
alterations of the amygdala structure; and 3) several pa-
tients reported partial remission (HDRS > 7) after treat-
ment in our study, potentially contributing to the




the center for pre-treatment group
the center for post-treatment group
pre- and post-treatment groups. The red cross (x) indicates the
the pre-treatment group. The blue circle (o) indicates the DBOLDLR
-treatment group. The red diamond (◆) and blue square (■) represent
line is represented by y = −13.139x + 390.392 (R2 = 0.203, F = 9.662,
nd left amygdalae.
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amygdala activity during emotion processing tasks in
people with various forms of mental illness. Most of
these reports suggest that amygdala reactivity to nega-
tive facial stimuli is exaggerated in people with depression.
Among these studies, Suslow and colleagues produced a
representative report showing how depressed patients
exhibit increased right amygdala reactivity in response to
masked negative facial emotions and decreased activity in
response to masked positive facial emotions, in contrast to
healthy comparison participants [35]. Therefore, there
appears to be a negative correlation between severity of
depression and right amygdala reactivity in response to
happy facial stimuli.
In this study, we investigated pre- and post-treatment
responsiveness in the left and right amygdalae. Like previ-
ous studies, we found a normalization of amygdala re-
sponses after antidepressant treatment, but no statistically
significant unilateral differences in BOLD signals in the
pre- and post-treatment amygdalae. Various factors may
have affected our findings, such as severity of illness at
the time of inclusion in the study, level of response,
previous treatment, previous number of episodes, and
use of medication, e.g. benzodiazepines. Additionally,
we only assessed changes within a population of
depressed individuals, and did not have a control group.
However, to the best of our knowledge, we are the first
to report a negative correlation between disease severity
and right-left differences in amygdala response. Thus,
we suggest that unilateral differences in BOLD signal
may be useful as an index or marker of depression.
Future studies may reveal more about individual varia-
tions in response to emotion stimuli.Conclusions
We sought to examine changes in amygdala activity in
response to antidepressant treatment. We found a signifi-
cant difference in unilateral BOLD signals between our
pre- and post-treatment period. Specifically, 16 partici-
pants exhibited enhanced unilateral differences in BOLD
signals after antidepressant treatment, with decreased
HDRS. However, four participants showed no significant
differences in BOLD signals or HDRS after antidepressant
treatment. Depression is a heterogeneous disorder with a
highly variable course, an inconsistent response to treat-
ment, and no established mechanism. This study presents
one approach to understanding the biological mechanisms
of major depression [35]. In the future, changes in BOLD
signals as revealed by fMRI might be useful in evaluating
the clinical manifestation of major depression.Competing interests
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